• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

April 15, 2022 Laurence Zitvogel Editor's Choice, Pharma & Human Health

 

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • MaaT Pharma Announces Positive Results from Pivotal Phase 3 ARES Study
    January 8, 2025
  • Lallemand’s New R&D Laboratories: An Exclusive Interview with Sylvie Binda, VP of R&D
    November 15, 2024
  • Health Canada Licenses Probiotical’s PROBIAL DERM® for Eczema and Atopic Dermatitis Claims
    October 22, 2024
  • Precision metagenomics: a rapid solution for identifying and characterizing microbial agents of infectious disease.
    October 17, 2024
  • Exhaling Clues to the Activity of the Microbiome with Owlstone’s Breath Biopsy Technology – An Interview with Dr. Liz Crone
    October 15, 2024
sign up

Sign up to the Microbiome Times newsletter